{"id":37469,"date":"2025-02-13T12:29:32","date_gmt":"2025-02-13T12:29:32","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=37469"},"modified":"2025-02-13T12:29:32","modified_gmt":"2025-02-13T12:29:32","slug":"ensemble-feasibility-cluster-trial-impact-on-patient-anxiety-and-quality-of-life-of-a-training-package-for-evaluation-of-dementia-symptoms-in-primary-care-using-test-bundles","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/tr\/integrated-care-board\/research-and-evidence\/our-research-portfolio\/nihr-funded-projects\/ensemble-feasibility-cluster-trial-impact-on-patient-anxiety-and-quality-of-life-of-a-training-package-for-evaluation-of-dementia-symptoms-in-primary-care-using-test-bundles\/","title":{"rendered":"Toplu Uygulanabilirlik K\u00fcme Deneyi: Birinci basamak sa\u011fl\u0131k hizmetlerinde demans semptomlar\u0131n\u0131n de\u011ferlendirilmesi i\u00e7in test paketleri kullan\u0131larak geli\u015ftirilen bir e\u011fitim paketinin hasta kayg\u0131s\u0131 ve ya\u015fam kalitesi \u00fczerindeki etkisi"},"content":{"rendered":"<div class=\"assembler_default-group assembler_module_group assembler_default-group_1 assembler_module_group_1\"><div class=\"assembler_module_area assembler_module_area_1\"><div class=\"assembler_text-module assembler_module assembler_text-module_1 assembler_module_1  transparent\"><a tabindex=\"-1\" title=\"Mod\u00fcl-1 ba\u015fl\u0131kl\u0131 b\u00f6l\u00fcm\" id=\"module-1\" href=\"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/37469\/#module-1\" class=\"anchor\"><span class=\"hidden\">Mod\u00fcl-1 ba\u015fl\u0131kl\u0131 b\u00f6l\u00fcm<\/span><\/a><!-- Template found for text-module - Template: template-text - Matched: _only --><section class=\"w-full mx-auto max-w-content pt-12 sm:pt-24 pb-12 sm:pb-24\">\r\n  <div class=\"entry-content w-full !px-0 max-w-small\">\r\n        <h1>Toplu Uygulanabilirlik K\u00fcme Deneyi: Birinci basamak sa\u011fl\u0131k hizmetlerinde demans semptomlar\u0131n\u0131n de\u011ferlendirilmesi i\u00e7in test paketleri kullan\u0131larak geli\u015ftirilen bir e\u011fitim paketinin hasta kayg\u0131s\u0131 ve ya\u015fam kalitesi \u00fczerindeki etkisi<\/h1>\n<h2>Finansman<\/h2>\n<p>Ulusal Sa\u011fl\u0131k ve Bak\u0131m Ara\u015ft\u0131rma Enstit\u00fcs\u00fc (NIHR) Hasta Yarar\u0131na Ara\u015ft\u0131rma (RfPB) Ref. NIHR207180<\/p>\n<h2>Ara\u015ft\u0131rma sorusu nedir?<\/h2>\n<ol>\n<li>\u00c7al\u0131\u015fma grubumuzla birlikte, pratisyen hekimlerin ilk klinik g\u00f6r\u00fc\u015fmelerine dayanarak, bili\u015fsel semptomlar\u0131n de\u011ferlendirilmesi i\u00e7in sa\u011fl\u0131k bak\u0131m asistanlar\u0131ndan talep edebilecekleri \u00fc\u00e7 test mod\u00fcl\u00fc tasarlad\u0131k; bu mod\u00fcllerde tan\u0131sal do\u011fruluk ve hastan\u0131n sunumuna duyarl\u0131 olma gereklili\u011fi dikkate al\u0131nd\u0131. (WP1)<\/li>\n<li>Test mod\u00fcllerini sunmak \u00fczere, geni\u015f bir kitleye \u00f6l\u00e7eklenebilir ve uygulanabilir, bilgi ve g\u00fcveni art\u0131ran ve yeterli kalite g\u00fcvencesini sa\u011flayan bir e\u011fitim paketi birlikte tasarlay\u0131n. En az 80% personel bu e\u011fitimi tamamlay\u0131p akreditasyon alabilir mi? (WP2)<\/li>\n<li>Birinci basamak sa\u011fl\u0131k hizmetlerinde, belirtileri olan ki\u015filere bili\u015fsel de\u011ferlendirmeler sunmak \u00fczere pratisyen hekimlere ve sa\u011fl\u0131k bak\u0131m asistanlar\u0131na y\u00f6nelik bir e\u011fitim paketinin geni\u015f \u00f6l\u00e7ekli bir denemesinin uygulanabilirli\u011fini belirleyin. Her uygulama i\u00e7in ayda 5 hastan\u0131n dahil edilmesi ve ba\u015flang\u0131\u00e7 ve takip a\u015famalar\u0131nda 80% kullan\u0131labilir \u00f6l\u00e7\u00fcm\u00fcn\u00fcn elde edilmesi m\u00fcmk\u00fcn m\u00fcd\u00fcr? (WP3)<\/li>\n<\/ol>\n<h2>Sorun nedir?<\/h2>\n<p>Demans, Birle\u015fik Krall\u0131k ekonomisine y\u0131lda 23 milyar sterline mal oluyor; bu rakam kalp hastal\u0131\u011f\u0131, fel\u00e7 ve kanserden daha fazla. \u0130ngiltere&#039;de yakla\u015f\u0131k 676.000 ki\u015fi demans hastas\u0131 ve 540.000 bak\u0131c\u0131 bulunuyor. Demans te\u015fhisi, bak\u0131c\u0131lara destek ve refah kaynaklar\u0131 sa\u011flamada \u00f6nemli bir ad\u0131md\u0131r ve ayr\u0131ca verilen bak\u0131m\u0131n \u015feklini belirlemeye de yard\u0131mc\u0131 olabilir. Demans i\u00e7in genel pratisyen hekim sevk modelleri ve te\u015fhis oranlar\u0131, farkl\u0131 ge\u00e7mi\u015flere sahip ki\u015filer i\u00e7in farkl\u0131l\u0131k g\u00f6sterebilir. Demans ila\u00e7lar\u0131, semptomlar\u0131n ilerlemesini yava\u015flatabilir ve insanlar\u0131n ba\u011f\u0131ms\u0131z kalmalar\u0131na ve evlerinde ya\u015famalar\u0131na yard\u0131mc\u0131 olabilir. Demans belirtileri ya\u015famak ve te\u015fhis beklemek \u00e7ok endi\u015fe verici bir s\u00fcre\u00e7 olabilir.<\/p>\n<h2>Ara\u015ft\u0131rman\u0131n amac\u0131 nedir?<\/h2>\n<p>Bu ara\u015ft\u0131rma, birinci basamak sa\u011fl\u0131k hizmetlerinde demans semptomlar\u0131n\u0131 de\u011ferlendirmek i\u00e7in testler yapma konusunda personele destek sa\u011flamak amac\u0131yla, \u00f6l\u00e7eklenebilir bir e\u011fitim geli\u015ftirmeyi ve test etmeyi ama\u00e7lamaktad\u0131r. Bir denemeye kat\u0131l\u0131mc\u0131 bulman\u0131n uygulanabilirli\u011fini ve kabul edilebilirli\u011fini, ayr\u0131ca testlerin hasta ve destekleyici kayg\u0131s\u0131 ve ya\u015fam kalitesi \u00fczerindeki etkisini \u00f6l\u00e7menin uygulanabilirli\u011fini de\u011ferlendirmeyi hedefliyoruz.<\/p>\n<h2>Bu nas\u0131l ba\u015far\u0131lacak?<\/h2>\n<p>Demans\u0131 tek ba\u015f\u0131na do\u011frulamak i\u00e7in hi\u00e7bir test yeterli de\u011fildir ve standart testler bireysel fakt\u00f6rleri hesaba katmaz. Te\u015fhis genellikle yap\u0131land\u0131r\u0131lm\u0131\u015f bir \u00f6yk\u00fc, bili\u015fsel test, bir yak\u0131ndan al\u0131nan bilgi ve g\u00fcnl\u00fck i\u015flevselli\u011fin testini gerektirir. Hangi testlerin kullan\u0131laca\u011f\u0131 bireye ve semptomlara ba\u011fl\u0131d\u0131r. Daha \u00f6nce birinci basamak sa\u011fl\u0131k hizmetlerinde hangilerinin iyi \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 bulmak i\u00e7in \u00e7e\u015fitli testleri kar\u015f\u0131la\u015ft\u0131rd\u0131k ve birinci basamak sa\u011fl\u0131k hizmetlerinde te\u015fhise yard\u0131mc\u0131 olabilecek yeni bir teknoloji \u00fczerinde \u00e7al\u0131\u015f\u0131yoruz. Hangi testlerin kim i\u00e7in i\u015fe yarad\u0131\u011f\u0131n\u0131 belirlemek ve hastan\u0131n sahip oldu\u011fu semptomlara dayanarak birinci basamak hekimlerinin hastalarla kullanabilece\u011fi 2-3 test mod\u00fcl\u00fc geli\u015ftirmek istiyoruz.<\/p>\n<p>Yakla\u015f\u0131m\u0131m\u0131z, uzmanlar\u0131n en zorlu tan\u0131sal vakalara odaklanarak bak\u0131m sa\u011flamaya devam etmelerini destekleyecek, ancak baz\u0131 ki\u015filerin aile hekimleri taraf\u0131ndan te\u015fhis edilmesine de olanak tan\u0131yacakt\u0131r.<\/p>\n<p>Mevcut a\u011flardan yararlanarak, hastalar, destek\u00e7iler, klinisyenler, sosyal bak\u0131m ve \u00fc\u00e7\u00fcnc\u00fc sekt\u00f6rle birlikte \u00e7al\u0131\u015farak, e\u011fitimli bir sa\u011fl\u0131k g\u00f6revlisi taraf\u0131ndan birinci basamak sa\u011fl\u0131k hizmetlerinde yap\u0131labilecek demans semptomlar\u0131na y\u00f6nelik 2-3 &quot;mod\u00fcl&quot; test geli\u015ftirece\u011fiz. E\u011fitimli bir pratisyen hekim, bu testlerin sonu\u00e7lar\u0131n\u0131 klinik bir g\u00f6r\u00fc\u015fmeyle birlikte tan\u0131 koymak ve re\u00e7ete yazmak i\u00e7in kullanacakt\u0131r. Gelecekteki deneme i\u00e7in uygulanabilirli\u011fi ve uygunlu\u011fu sa\u011flamak amac\u0131yla, y\u00fcksek yoksulluk oran\u0131na sahip b\u00f6lgelerdeki 75 ya\u015f \u00fcst\u00fc yeti\u015fkinlerle ve k\u00fcresel \u00e7o\u011funluktaki ki\u015filerle yak\u0131n i\u015fbirli\u011fi i\u00e7inde \u00e7al\u0131\u015faca\u011f\u0131z. Bu testler i\u00e7in bir e\u011fitim paketi geli\u015ftirece\u011fiz. Birinci basamak sa\u011fl\u0131k hizmetlerinde bir deneme yapman\u0131n pratik sorunlar\u0131n\u0131 de\u011ferlendirecek, hasta ve bak\u0131c\u0131lar\u0131n ya\u015fam kalitesini ve kayg\u0131lar\u0131n\u0131 \u00f6l\u00e7ecek ve elektronik kay\u0131t takibi kullanarak hasta sonu\u00e7lar\u0131na bakaca\u011f\u0131z.<\/p>\n<p>\u00c7al\u0131\u015fmalar\u0131m\u0131z\u0131 tasarlamak, yorumlamak ve yaymak konusunda bize destek olacak, deneyimli uzmanlardan olu\u015fan bir ortakl\u0131k grubu olu\u015fturduk.<\/p>\n<h2>Ara\u015ft\u0131rmay\u0131 kim y\u00f6netiyor?<\/h2>\n<p>Dr Sam Creavin, NIHR Genel Pratisyenlik Klinik \u00d6\u011fretim G\u00f6revlisi, <a href=\"https:\/\/www.bristol.ac.uk\/medical-school\/research\/population-health-sciences\/\" rel=\"noopener\">Bristol T\u0131p Fak\u00fcltesi (PHS)<\/a>.<\/p>\n<h2>Daha Fazla Bilgi<\/h2>\n<p>CI E-postas\u0131: <a href=\"mailto:Sam.Creavin@bristol.ac.uk\">Sam.Creavin@bristol.ac.uk<\/a><\/p>\n<p>Daha fazla bilgi almak veya bu projeye kat\u0131lmak i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7in.\u00a0<a href=\"mailto:bnssg.research@nhs.net\">bnssg.research@nhs.net<\/a>.<\/p>\n<p>Burada ifade edilen g\u00f6r\u00fc\u015fler yazar(lar)a aittir ve NIHR veya Sa\u011fl\u0131k ve Sosyal Bak\u0131m Bakanl\u0131\u011f\u0131&#039;n\u0131n g\u00f6r\u00fc\u015flerini yans\u0131tmayabilir.<\/p>\n  <\/div>\r\n  <\/section><\/div><!-- .assembler_text-module.assembler_module.assembler_text-module_1.assembler_module_1..transparent --><\/div><!-- .assembler_module_area.assembler_module_area_1 --><\/div><!-- .assembler_default-group.assembler_module_group.assembler_default-group_1.assembler_module_group_1  -->","protected":false},"excerpt":{"rendered":"<p>Section titled module-1 Ensemble Feasibility Cluster Trial: Impact on patient anxiety and quality of life of a training package for evaluation of dementia symptoms in primary care using test bundles Funding National Institute for Health and Care Research (NIHR) Research for Patient Benefit (RfPB) Ref. NIHR207180 What is the Research Question? Co-design with our PG, [&hellip;]<\/p>\n","protected":false},"author":28,"featured_media":0,"parent":32881,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-37469","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/37469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/comments?post=37469"}],"version-history":[{"count":2,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/37469\/revisions"}],"predecessor-version":[{"id":37471,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/37469\/revisions\/37471"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/32881"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/media?parent=37469"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/tags?post=37469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}